Whilst this may only be the case in a small number of individuals, we believe it is particularly noteworthy as, out of the 54 AQP4-Ab NMOSD patients (randomly sampled from the Oxford NMO clinic) included in this study, 7% (n = 4) were seronegative at the time of sampling. The gene discussed is AQP4; the disease is neuromyelitis optica.